Salitic 16.7%+16.7%

Salitic 16.7%+16.7% | INDICATIONS AND USES

This is a topical solution indicated in the treatment of warts, corns and calluses.Information For Patients

Warts: A wart is a viral infection of the surface layers of the skin. The incubation period varies from a few weeks to several months. Warts can spread by direct contact with a wart to damaged skin. ... Read moreThis is a topical solution indicated in the treatment of warts, corns and calluses.Information For Patients

Warts: A wart is a viral infection of the surface layers of the skin. The incubation period varies from a few weeks to several months. Warts can spread by direct contact with a wart to damaged skin.
Corns: A corn is a small, hardened area of skin which often looks yellow compared to the surrounding skin. It is typically round or cone-shaped, pointing down into the skin. Corns most often form on the feet and sometimes on the hands and are caused by constant or repeated friction or pressure.
Calluses: A callus is rough, thickened skin spread over a wide area. Like a corn, it is caused by constant or repeated friction or pressure, but unlike corns, calluses are flat and have normal skin markings.

Salitic 16.7%+16.7% | PHARMACOLOGY

Salicylic acid is a widely used and effective keratolytic, it produces desquamation and destruction of the epithelium by solubilising the intercellular cement of the Stratum Corneum. Lactic acid affects the keratinisation process, reducing hyperkeratosis and is also caustic, leading to the destruction of hyperkeratotic tissue. Collodion is derived from cellulose in a base containing ethanol and ether. It allows easy and accurate application of the product and dries to leave a film which hydrates the tissue and facilitates penetration of the active ingredients.

Salitic 16.7%+16.7% | DOSAGE & ADMINISTRATION

Unscrew bottle cap and with the help of brush applicator, apply to the affected areas. ‘Before starting to use this topical solution, unscrew the fitted cap, discard it. Carefully remove the plug away from your body to avoid splashing into eyes/ face and discard it, replace with the brush applicator cap provided inthe sealed polybag given in the carton. This topical solution should be applied to the affected areas once daily, according to the following instructions:

Soak affected site in hot water for five minutes.
Rub surface carefully with pumice stone or emeryboard to remove any hard skin. Dry with your own towel.
Apply this topical solution using the brush applicator supplied, taking care to avoid contact with normal skin.
Allow to dry thoroughly and cover with plaster if lesion is large or on the foot to help penetration of active ingredients.
Continue treatment once daily until the lesion is completely cleared and the ridge lines of the skin have been restored or when the corn can be removed.
The usual treatment period is 6 to 12 weeks.

Salitic 16.7%+16.7% | DRUG INTERACTIONS

This topical solution may increase the absorption of other topically applied medicines. Therefore, concomitant use of this topical solution and other topical medicines on the treated area should be avoided. As systemic exposure of topically applied this topical solution is low, interaction with systemically administered medicines is not anticipated.

Salitic 16.7%+16.7% | SIDE EFFECTS

Adverse drug reactions (ADRs) are listed below by MedDRA system organ class and by frequency. Frequencies are defined as: very common (≥1/10), common (≥1/100 and <1/10), uncommon (≥1/1,000 and <1/100), rare (≥1/10,000 and <1/1,000) and very rare (<1/10,000), including isolated reports.Rash (common), Skin and subcutaneous tissue disorders: Application site reaction, pruritus, burning sensation, erythema, scaling, dryness (Very common), Skin hypertrophy (Common).Toxicities: In the event of accidental oral ingestion symptoms of salicylate toxicity may occur. The risk of developing symptoms of salicylate poisoning or salicylism is increased if this solution is used excessively or if it is used for prolonged periods of time. Therefore, duration of use and recommended frequency compliance is very important. Management should be as clinically indicated.

Salitic 16.7%+16.7% | USE DURING PREGNANCY AND LACTATION

The safety of this solution during human pregnancy has not been established. Studies in animals given salicylic acid orally demonstrated embryo toxicity at high doses. D-film is not recommended during pregnancy. Salicylates are excreted in human milk. This solution is not recommended during lactation. If used or administered during lactation, care should be taken to avoid contact with the breast area in order to avoid accidental ingestion by the infant.

Salitic 16.7%+16.7% | PRECAUTIONS & WARNINGS

This preparation is formulated for the controlled corrosion of keratin and thus care should be taken to apply the product to the affected area only. Do not use on the face or anogenital regions or if you are diabetic or have impaired circulation. Do not use on moles, birthmarks or unusual skin growths. Do not treat warts over large areas at one time, or use on infants and very young children unless on medical advice. For External Use Only

Salitic 16.7%+16.7% | THERAPEUTIC CLASS

Combined preparations

Salitic 16.7%+16.7% | STORAGE CONDITIONS

In view of its high inflammability, it is recommended that Salicylic Acid & Lactic Acid be stored in a cool place not exceeding 25°C. Keep away from naked flame. Keep out of reach of children. Since this topical solution is volatile, close the bottle tightly after each use.